We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.55% | 9.15 | 8.80 | 9.50 | 9.15 | 8.86 | 9.10 | 1,054,095 | 12:15:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.09 | 84.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/3/2023 20:46 | Pfizer on Monday said it has agreed to buy cancer drugmaker Seagen for $43 billion in cash. | plasybryn | |
13/3/2023 18:30 | Banks I'd guess MT - weighting of the markets and US dollar weakness of course. | nigelpm | |
13/3/2023 17:46 | ....the rest of the UK msrket, perhaps....but the US market is currently up on the day, so heaven knows what the UK market is playing at.... | markingtime | |
13/3/2023 17:24 | Well, judging by the rest of the market, I think we can conclude that has been a good day for Scancell investors. | dominiccummings | |
13/3/2023 15:18 | Lovely sunny day - 29 C in the sun S facing terrace earlier This morning we had the pleasure of a lengthy visit by a Red Kite hunting, passing low over the land, giving a great display of that big red forked tail that allows such a big bird the agility to twist and turn. Matched only verbally by inane'n'co | the real lozan | |
13/3/2023 14:55 | the vaccine season does not start again til Sept ... its spring P7 you can take a well deserved Holiday | inanaco | |
13/3/2023 12:36 | AN independent lab has found the Pfizer and Moderna Covid jabs are contaminated with double stranded DNA – 100 times the limit allowed by the European Medicines Agency (EMA). THE TRUTH IS OUT THERE !!!! | panama7 | |
13/3/2023 11:11 | Avidimab has been used (and improved) one of Seagen`s antibodies so we can presume that Pfizer will now know about it. | marcusl2 | |
13/3/2023 11:11 | ....so 10% or so above Merck's offer from last year....what will Merck do now to defend it's patent cliff on Keytruda? Surely what they need is to prove effectiveness for Keytruda in combination with something else???? | markingtime | |
13/3/2023 11:04 | Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion | marcusl2 | |
13/3/2023 10:50 | "I just bought more" ??? A bit of a non event one way or another really. The time to worry or pay attention as *WE ALL* know, ,is when inane'n'co 'brags' about HE has employed the BUY,BUY,BUY (and HAS to HOLD) passport to FAILURE | the real lozan | |
13/3/2023 09:58 | Good call, DC, both from a strategic standpoint and a market opportunity standpoint. | markingtime | |
13/3/2023 09:48 | The percentage change from $3 to $25 is an increase of 733.33%. 17p to £1.41p would be nice! ;-) | marcusl2 | |
13/3/2023 09:47 | Interesting points made about deals and valuation in the antibody sector. Worth bearing in mind perhaps - with a risk hat on - that for all the discussion about moditope pass/fail, the other assets represent more than half of the valuation in the TD sum of parts. | wigwammer | |
13/3/2023 09:27 | Huge money in Antibodies and Bi-specifics. Gilead pledging up to $1.7 billion in biobucks for the phase 1 bispecific antibody. Lilly licenses Merus antibody therapy for up to $1.6 billion Sanofi inks US$2.5 billion deal with Adagene to develop cancer antibodies | marcusl2 | |
13/3/2023 08:43 | I just bought more | dominiccummings | |
13/3/2023 08:12 | Good to get clarification that Scancell was not with SVB Best banking with a bank that is too big to fail. Janet Yellen is back-stopping SVB’s depositors and Silicon Valley Bank's UK subsidiary has been sold to HSBC for £1 | marcusl2 | |
13/3/2023 07:47 | Scancell Holdings Plc 13 February 1637 Scancell Holdings plc ("Scancell" or the "Company") Statement re: Tulip Market Following the precipitous decline in Tulip Futures, Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, can confirm that it has no investments in The Tulip Investment Bank. This announcement follows the closure of the Tulip Investment Bank by the Dutch Investment in Cultivation, Horticulture and Exotic Agriculture Department (DICHEAD) Professor Lindy Durrant. | goyathlay | |
13/3/2023 07:10 | Very good to see the pre-emptive confirmation that there is no relationship with SVB! Healtb/tech ompanies that haven't done that would have been exposed to speculation if the government hadn't just announced that it has brokered the sale of SVB UK to HSBC. | markingtime | |
12/3/2023 21:41 | Inane, interesting you talk about Mice, shame you didn't research the Animal data for the Corona vaccines. | panama7 | |
12/3/2023 11:08 | "exceptional IQ" Lord RuckRover of Camberwick Green Commented "What I have done through careful analysis" ............. have decided that ""No one can predict any single value with certainty"" giving us a range of "8p to 80p" Dates of upcoming lectures on my analysis will be presented at Colley's Mill, Bell's farm, Tripp's Dairy, and Pippin Fort. Titled "plausible nonsense" | inanaco | |
12/3/2023 08:42 | " we now have a bank full of Ruck predictions" What I have done through careful analysis, is come up with an estimate range that is realistic. No one can predict any single value with certainty as there are at this stage too many unknowns and variables. So in the short term, all I can say is that anything in the range 8p to 80p is possible. | ruckrover |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions